🧠Mind & Mental Health
Global Study Tracks Adoption Rates of Long-Acting Antipsychotics in Schizophrenia Care
A meta-analysis involving more than 1.6 million participants found that 18.7 percent of individuals with schizophrenia receive long-acting injectable antipsychotics. Pres…